Procedural results and long-term clinical outcomes following coronary stenting in perimyocardial infarction syndromes

American Journal of Cardiology

Volumn 82, Issue 10, 1998, Pages 1163-1167

  Kornowski, Ran ^a   Hong, Mun K ^a   Saucedo, Jorge ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Kent, Kenneth M ^a   Greenberg, Ann ^a   Leon, Martin B ^a,b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Washington Cardiology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; FEMALE; HEART INFARCTION; HEART REINFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STENT; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; SYNDROME; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROBABILITY; RECURRENCE; STENTS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0032533433     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00600-6     Document Type: Article

References (20)

1. 1. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Pickard AF, Meier B, Goy JJ, Vogt P, Kappenberger L, Sigwart U. Angiographic follow-up after placement of a self-expanding coronary artery stent. N Engl J Med 1991;324:13-17.
2. 2. Sutton JM, Wliis SG, Roubin GS, Pinkerton CA, King SB, Raizner AE, Holmes DR, Kereiakes DJ, Topol EJ. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994;89:1126-1137.
3. 3. Fuster V, Badimon L, Chesebro J. The pathogenesis of coronary artery disease and the acute coronary syndromes: parts I & II. N Engl J Med 1992:326:242-250, 310-318.
4. 4. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promote smooth muscle cell migration and intimal thikening in a rat model of balloon angioplasty. J Clin Invest 1992;89:507-11.
5. 5. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neoinitimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
6. 6. Fager G. Thrombin and proliferation of smooth muscle cells. Circ Res 1995;77:645-50.
7. 7. Wong PHC, Wong CM. Intracoronary stenting in acute myocardial infarction. Cathet Cardiovasc Dis 1994;33:39-45.
8. 8. Walton AS, Oesterle SN, Yeung AC. Coronary artery stenting for acute closure complicating primary angioplasty for acute myocardial infarction. Cathet Cardiovasc Dis 1995; 34:142-146.
9. 9. Ahmad T, Webb JG, Carere RR, Dodek A. Coronary stenting for acute myocardial infarction. Am J Cardiol 1995; 76:77-80.
10. 10. LeMay MR, Labinaz M, Beanland RB, Laramee LA, O'Brien ER, Marwuiz JF, Williams WL, Al-Sadoon K, Davies RF, Kearns SA, Johansen HL, Higginson LA. Usefulness of intracoronary stenting in acute myocardial infarction. Am J Cardiol 1996;78:148-152.
11. 11. Saito S, Hosokawa G, Kim K, Tanaka S, Miyake S. Primary stent implantation without coumadin in acute myocardial infarction. J Am Coll Cardiol 1996;28:74-81.
12. 12. Stone GW, Brodie BR, Griffin JJ, Claude Morice M, Costantini C, Goar FG, Overlie PA, Popma JJ, McDonnell J, Jones D, O'Neill WW, Grines CL. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998;31:23-30.
13. 13. Monassier JP, Hamon M, Elias J, Maillard L, Spaulding C, Raynaud P, Cribier A, Barragan P, Juliard JM, Lefevere T, Aubry P, Faugier JP, Masquet C, Rioux P, Bedossa M, Joly P, Pititeau PY, Royer T, Morice MC, Roriz R, Cattan S, Meyer P, Blanchard D, Khalife K. Early versus late coronary stenting following acute myocardial infarction: results of the STENTIM I study (french registry of stenting in acute myocardial infarction). Cathet Cardiovasc Diagn 1997;42: 243-248.
14. 14. Brodie BR, Grines CL, Ivanhoe R, Knopf W, Taylor G, O'Keefe J, Weintraub RA, Berdan LG, Tcheng JE, Woodlief LH, Califf RM, O'Neill WW. Six month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Circulation 1994;25:156-162.
15. 15. Grines CL. Aggressive intervention for myocardial infarction: angioplasty, stents, and intra-aortic balloon pumping. Am J Cardiol 1996;78(suppl 3A):29-34.
16. 16. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the STent REStenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
17. 17. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA, for the BENESTENT Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
18. 18. Alfonzo F, Rodriguez p, Phillips p, GoicoleA j, Hernandez R, Perez-Vizcayno MJ, Fernandez-Ortiz A, Segovia J, Banuelos C, Aragoncillo p, Macaya C. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol 1997;29:725-733.
19. 19. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigation. N Engl J Med 1994;330:956-961.
20. 20. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.